- Category Marryalyan
- DATE 29 May 2024
Breast Cancer Trials
May 2024
45th Annual Scientific Meeting
The Cairns Convention Centre in Queensland will host the Breast Cancer Trials 45th Annual Scientific Meeting (ASM), from 24 -26 July 2024.
This is the premier event to stay up to date with breast cancer clinical trials research, and delegates include leading Australian and New Zealand medical practitioners, clinicians, and clinical trials management personnel.
Breast Cancer Trials has a strong history of bringing the world’s best and brightest minds to the ASM each year and our international guest speakers are:
- Associate Professor Erica Mayer – Director of Clinical Research and an Institute Physician in the Breast Oncology Centre at the Dana-Farber Cancer Institute, and Associate Professor in Medicine at Harvard Medical School in the United States.
- Professor Michel Gnant – Professor of Surgery at the Medical University of Vienna, Austria, where he also serves as President of the Austrian Breast & Colorectal Cancer Study Group.
- Dr Carlos Barrios – Adjunct Assistant Professor of the William Harrington Latin American Program at the University of Miami School of Medicine, Director and Principal Investigator of the Oncology Research Centre at Hospital Sao Lucas, and Director of Clinical Research and Oncologist of the Oncoclinicas Group in Porto Alegre.
- Professor Andrew Tutt – Head of the Division of Breast Cancer Research and Director of the Breast Cancer Now Tony Robins Research Centre at the ICR and Guy’s Hospital King’s College London.
- Professor Elinor Sawyer – Consultant Clinical Oncologist at Guy’s & St Thomas’ Hospital and Professor of Oncology at King’s College London.
- Dr Peter Barry – Consultant Surgeon at The Breast Uni, Royal Mardsen.
- Professor In Hae Park – Professor in the division of Hemato-Oncology at the Korean University College of Medicine and Guro Hospital.
- Dr Akihiko Shimomura – National Cancer Centre Hospital, Tokyo, Japan, and representative from the Japan Clinical Oncology Group.
The extensive program includes:
- two days of scientific sessions covering timing reviews of research developments.
- the discussion of new protocols and future clinical trials research.
- sponsored breakfast and lunch symposium sessions.
- a conference dinner at the Convention Centre.
- a trainee and early career weekend on 27 and 28 July.
Early-bird registration, abstracts, new concept applications, and Trainee and Early Career Grants, will close on Friday 31 May.
To register or find out more, visit www.bct2024.org.
Open Clinical Trials
We recently opened two new trials – OPTIMA and CAMBRIA-2.
OPTIMA aims to find out if using a test called Prosigna, can help make safe and accurate decisions about whether or not chemotherapy treatment is needed for patients with ER-positive, HER2-negative early breast cancer.
CAMBRIA-2 is investigating if giving a new treatment called camizestrant is better at stopping cancer from coming back, for patients with ER-positive, HER2-negative early breast cancer, compared to the usual endocrine (hormone) treatments such as letrozole, anastrozole, exemestane or tamoxifen.
Other trials currently open are:
- BRCA-P – a world-first trial that aims to prevent breast cancer in women with a BRCA1 gene mutation.
- CAPTURE – aims to identify women and men with hormone-receptor positive metastatic breast cancer, who many benefit from a novel combination of drugs that may improve progression free survival.
- EXPERT – aims to improve personalised use of radiation therapy in early breast cancer patients, by using a genomic test to identify women who can safely avoid this treatment after surgery and the potential side effects.
- TUGETHER – aims to find out if adding tucatinib and pembrolizumab to the usual treatment given to people with advanced HER2-positive breast cancer, slows down the growth of the cancer.
Q&A Event: Is Less More
Join our next free and online Q&A on the topic of ‘Is Less More: Rethinking Breast Cancer Treatment’, moderated by Author and Journalist Annabel Crabb.
The Q&A will be held on 12 June from 5-6:30pm (AEST) and will discuss optimised treatment and identifying patients who may benefit from having less treatment. Featuring Professor Boon Chua, Dr Belinda Kiely, Ms Michelle Sinclair and Ms Margaret Lopreiato, the Q&A panel will discuss research such as the EXPERT, OPTIMA and PROSPECT clinical trials, as well as recent findings on the psychological impact of optimised treatment on patients, and a patient’s perspective on choosing to have less treatment and her breast cancer outcomes. |
|
To find out more or to register, click here.
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow
COSAoncology one month ago
Congratulations Ashfaq Chauhan for recognition of your work to enhance cancer care for people from CALD backgrounds.
Read More >COSAoncology one month ago
Congratulations @DrNicolasHart for recognition of your work to improve outcomes of all people affected by cancer.
Read More >COSAoncology one month ago
Congratulations @yapml for recognition of your important work in equity and cancer care.
Read More >COSAoncology 2 months ago
You have till this Friday 22 Nov '24 to submit an abstract for the National Cancer Survivorship Conference #Surv25 in Melbourne, 6-7 March. We particularly welcome submissions from survivors themselves and those whose work is in partnership with survivors https://t.co/6V4F3x1vvF https://t.co/vjp4hfcVXN
Read More >COSAoncology 2 months ago
You have till this Friday 22 Nov '24 to submit an abstract for the National Cancer Survivorship Conference #Surv25 to be held in Melbourne, March 2025. We particularly welcome submissions from survivors and those whose work is in partnership with survivors https://t.co/6V4F3x1vvF https://t.co/87PUAMTxwA
Read More >COSAoncology 5 days ago
Cancer Survivorship 2025 will showcase innovation in survivorship care, research, advocacy and policy. Health professionals and public are encouraged to attend. Earlybird registration closes this Friday 17 January. View the program and register at https://t.co/QMq00LQGmK #Surv25 https://t.co/BilfOCyd2m
Read More >COSAoncology one month ago
RT @oncodaily: Disability and cancer care – We can do both! - @ShonaEdwards2 @CVSAinfo @COSAoncology https://t.co/baqGDwRe8W #Cancer #Ca…
Read More >COSAoncology one month ago
RT @AYAGlobalCancer: Great to see how research has expanded in #AYA psychosocial care 🙌🏻 Dr Ursula Sansom-Daly @usansomdaly presents the up…
Read More >COSAoncology one month ago
Read the latest news from COSA and COSA members in our November eNewsletter. Check your inbox or login to your COSA member account to view now: https://t.co/5ib5Nlou8I https://t.co/ApABAA7WHN
Read More >COSAoncology one month ago
Congratulations David Thomas for recognition of your leadership and groundbreaking work in genomics in cancer care. And congratulations to all the recipients of the 2024 Premier's Awards for Outstanding Cancer Research. #cancerNSWawards
Read More >COSAoncology one month ago
Congratulations Ashfaq Chauhan for recognition of your work to enhance cancer care for people from CALD backgrounds.
Read More >COSAoncology one month ago
Congratulations @DrNicolasHart for recognition of your work to improve outcomes of all people affected by cancer.
Read More >COSAoncology one month ago
Congratulations @yapml for recognition of your important work in equity and cancer care.
Read More >COSAoncology 2 months ago
You have till this Friday 22 Nov '24 to submit an abstract for the National Cancer Survivorship Conference #Surv25 in Melbourne, 6-7 March. We particularly welcome submissions from survivors themselves and those whose work is in partnership with survivors https://t.co/6V4F3x1vvF https://t.co/vjp4hfcVXN
Read More >COSAoncology 2 months ago
You have till this Friday 22 Nov '24 to submit an abstract for the National Cancer Survivorship Conference #Surv25 to be held in Melbourne, March 2025. We particularly welcome submissions from survivors and those whose work is in partnership with survivors https://t.co/6V4F3x1vvF https://t.co/87PUAMTxwA
Read More >COSAoncology 5 days ago
Cancer Survivorship 2025 will showcase innovation in survivorship care, research, advocacy and policy. Health professionals and public are encouraged to attend. Earlybird registration closes this Friday 17 January. View the program and register at https://t.co/QMq00LQGmK #Surv25 https://t.co/BilfOCyd2m
Read More >COSAoncology one month ago
RT @oncodaily: Disability and cancer care – We can do both! - @ShonaEdwards2 @CVSAinfo @COSAoncology https://t.co/baqGDwRe8W #Cancer #Ca…
Read More >COSAoncology one month ago
RT @AYAGlobalCancer: Great to see how research has expanded in #AYA psychosocial care 🙌🏻 Dr Ursula Sansom-Daly @usansomdaly presents the up…
Read More >COSAoncology one month ago
Read the latest news from COSA and COSA members in our November eNewsletter. Check your inbox or login to your COSA member account to view now: https://t.co/5ib5Nlou8I https://t.co/ApABAA7WHN
Read More >COSAoncology one month ago
Congratulations David Thomas for recognition of your leadership and groundbreaking work in genomics in cancer care. And congratulations to all the recipients of the 2024 Premier's Awards for Outstanding Cancer Research. #cancerNSWawards
Read More >